Straumann Holding AG

OTC
SAUHY
Stock
Yield per half year: +11.76%
Dividend yield: 0.8529%
Sector: Healthcare

Straumann Holding AG

18.0018.0016.0016.0014.0014.0012.0012.0010.0010.00Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
51.78 54.97 -5.82% 51.81 -0.057%
P/S 8.03 5.01 60.41%
P/BV 8.93 5.89 51.53%
P/FCF 54.21 28.5 90.22%
Ev/Ebitda 27.75 18.25 52%
Ev/S 8.04 4.62 73.95%
Ev/FCF 57.91 42.28 36.99%
E/P 0.0206 1.42 -98.55%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
28.98 23.27 24.5% 29.52 -1.84%
ROE 17.53 14.7 19.21%
ROA 9.68 7.42 30.47%
ROIC 19.78 14.2 39.31%
ROS 15.49 11.61 33.39%
ROCE 25.87 17.11 51.22%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.6282 2.95 -78.73% 0.7348 -14.51%
Nеt Debt/Ebitda 0.0583 0.0289 101.64%
Debt/Ratio 0.1144 0.2166 -47.18%
Debt/Equity 0.7747 1.09 -29.07%
Debt/Net Income 1.17 9.8 -88.02%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
2.13/10
0.8529 1.72 -50.48% 0.3597 +137.09%
Number of years of dividend growth 3 1.67 79.53%
DSI 0.8571 0.7773 10.27%
Average dividend growth -34.31 -391.67 -91.24%
Average percentage for 5 years 0.3597 3.27 -89.02%
Average percentage for payments 75.14 159.36 -52.85%
Difference from average difference in sector -0.8693

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
6/10
42.37 376.09 -88.73%
Growth impulse Ebitda in 5 years 130.99 370.25 -64.62%
Growth impulse Net Income in 5 years 244.54 281.12 -13.01%
Growth impulse FCF in 5 years -4.32 257.32 -101.68%
Growth impulse EPS in 5 years -98.72 476.32 -120.73%
IP Score
5.59/10

Similar companies

Astellas Pharma Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription